Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1814
Small font sizeDefault font sizeIncrease font size
Navigate here
  Search
 
  
Resource links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (534 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References

 Article Access Statistics
    Viewed1544    
    Printed67    
    Emailed0    
    PDF Downloaded196    
    Comments [Add]    

Recommend this journal

 

  Table of Contents  
LETTER TO EDITOR
Year : 2011  |  Volume : 48  |  Issue : 3  |  Page : 378
 

Ki-67 as proliferative marker of thyroid


Wiwanitkit House, Bangkhae, Bangkok - 10160, Thailand

Date of Web Publication14-Sep-2011

Correspondence Address:
V Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok - 10160
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0019-509X.84927

Rights and Permissions



How to cite this article:
Wiwanitkit V. Ki-67 as proliferative marker of thyroid. Indian J Cancer 2011;48:378

How to cite this URL:
Wiwanitkit V. Ki-67 as proliferative marker of thyroid. Indian J Cancer [serial online] 2011 [cited 2019 Dec 16];48:378. Available from: http://www.indianjcancer.com/text.asp?2011/48/3/378/84927


Sir,

I read the recent report by Pujani et al. with a great interest. They concluded that "Ki-67 was found to be useful in differentiating between follicular adenoma and follicular carcinoma, but since the sample size of our study was small, larger studies are needed to confirm this observation as well as to assign a cutoff value for differentiating benign from malignant tumors." [1] As Pujani et al. noted, there are some limitations due to methodology of this report. Not only the few subjects but also no age and sex matched case control design are big problems that limit the clinical usefulness of this work. Indeed, there are also other left questions. The problems on the immunostaining of Ki-67 should also be discussed. False positive and false negative due to Ki- 67 tests are already reported in the study in colorectal cancer. [2]

 
  References Top

1.Pujani M, Arora B, Pujani M, Singh SK, Tejwani N. Role of Ki-67 as a proliferative marker in lesions of thyroid. Indian J Cancer 2010;47:304-7.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.Kuniyasu H, Oue N, Shigeishi H, Ito R, Kato Y, Yokozaki H, et al. Prospective study of Ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis. J Exp Clin Cancer Res 2001;20:543-8.  Back to cited text no. 2
[PUBMED]    




 

Top
Print this article  Email this article
 

    

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow